title: Evaluation of a pneumonia practice guideline in an interventional trial.
abstract: There are few available data to define the medically necessary duration of stay for patients hospitalized with pneumonia. Therefore, we investigated the safety and effectiveness of a practice guideline that provided information about switching patients from parenteral to oral antimicrobials and early hospital discharge. The study was a prospective controlled study with an alternate month design. The practice guideline was studied in 146 "low-risk" pneumonia patients hospitalized during a 22-month period. Medical care consistent with the practice guideline occurred in 64% and 76% of patients during control and intervention periods, respectively (p=0.15). There were no differences in patient outcomes in the control and intervention groups when measured 1 mo after hospital discharge, including hospital readmission rates, health-related quality of life, and patient satisfaction. Explicit and implicit review revealed that 98.6% (95% confidence interval [CI]: 95.1%, 99.8%) of low-risk patients would not have benefited from continued hospitalization after the fourth hospital day. The 30-d survival rate of the low-risk pneumonia patients was 99.3% (95% CI: 96.2%, 100%) and patient outcomes appeared to be favorable compared with previously published values. We conclude that duration of hospital stay was frequently consistent with the practice guideline in both study groups, and patient outcomes remained unchanged. The guideline will require additional testing before it can be recommended for use.
authors.affiliation: Department of Health Services Research, Department of Medicine, Cedars-Sinai Health System, University of California, Los Angeles School of Medicine, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Weingarten
authors.forename: M S
authors.initials: MS
authors.lastname: Riedinger
authors.forename: P
authors.initials: P
authors.lastname: Hobson
authors.forename: M S
authors.initials: MS
authors.lastname: Noah
authors.forename: B
authors.initials: B
authors.lastname: Johnson
authors.forename: G
authors.initials: G
authors.lastname: Giugliano
authors.forename: J
authors.initials: J
authors.lastname: Norian
authors.forename: M J
authors.initials: MJ
authors.lastname: Belman
authors.forename: A G
authors.initials: AG
authors.lastname: Ellrodt
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016001:Confidence Intervals; D005069:Evaluation Studies as Topic; D005260:Female; D006760:Hospitalization; D006801:Humans; D007263:Infusions, Parenteral; D007902:Length of Stay; D008297:Male; D010351:Patient Discharge; D010359:Patient Readmission; D017060:Patient Satisfaction; D011014:Pneumonia / Q000188:drug therapy / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D011788:Quality of Life; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents